1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Urticaria

1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Urticaria in 27 studies

Research

Studies (27)

Timeframe	Studies, this research(%)	All Research%
pre-1990	6 (22.22)	18.7374
1990's	8 (29.63)	18.2507
2000's	3 (11.11)	29.6817
2010's	8 (29.63)	24.3611
2020's	2 (7.41)	2.80

Authors

Authors	Studies
Gomułka, K; Mędrala, W	1
Cha, HY; Choi, BY; Jo, J; Jung, HW; Kang, HC; Park, HS; Shin, MK; Yang, EM; Ye, YM	1
Calogiuri, GF; Delle Donne, P; Di Leo, E; Ferrannini, A; Nettis, E; Vacca, A	1
Canonica, GW; Compalati, E	1
Badyal, DK; Johnson, M; Kwatra, G; Thomas, EA	1
Bartuzi, Z; Pałgan, K	1
Bachert, C; González-Núñez, V; Mullol, J	1
Cassano, N; Delle Donne, P; Di Leo, E; Foti, C; Nettis, E; Vacca, A; Vena, GA	1
Ferrán, M; Giménez-Arnau, A; Izquierdo, I; Maurer, M; Metz, M; Scholz, E	1
Maurer, M; Metz, M	1
Abajian, M; Church, MK; Farré-Albadalejo, M; Giménez-Arnau, A; Krause, K; Martinez-Escala, E; Maurer, M	1
Keam, SJ; Plosker, GL	1
Bachert, C; Bousquet, J; Canonica, WG; Gimenez-Arnau, A; Kowalski, ML; Martí-Guadaño, E; Maurer, M; Mullol, J; Picado, C; Scadding, G; Van Cauwenberge, P	1
Adkinson, NF; Lichtenstein, LM; MacGlashan, DW; Naclerio, R; Peters, SP; Proud, D; Schleimer, RP	1
Czarnetzki, B	1
Archer, CB; Brooks, J; Burton, JL; Sansom, JE	1
Czarnetzki, BM; Hartmann, K; Pfrommer, C; Schwarz, S; Zuberbier, T	1
Armenaka, M; Rosenstreich, DL	1
Juhlin, L; Pihl-Lundin, I	1
Becker, WM; Schade, U; Schaubschläger, WW; Schlaak, M; Zabel, P	1
Juhlin, L; Rihoux, JP	1
Juhlin, L	1
Fukuda, T; Makino, S	1
Eisenstadt, TC; Farr, RS; Grandel, KE; Wanderer, AA; Wasserman, SI	1
Archer, CB	1
Braquet, P; Cournot, A; Duchier, J; Guinot, P	1
Wasserman, SI	1

Reviews

9 review(s) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Urticaria

Article	Year
Rupatadine for the treatment of urticaria. Expert opinion on pharmacotherapy, 2013, Volume: 14, Issue:13 Topics: Animals; Cyproheptadine; Histamine Antagonists; Humans; Platelet Activating Factor; Urticaria	2013
Efficacy and safety of rupatadine for allergic rhino-conjunctivitis: a systematic review of randomized, double-blind, placebo-controlled studies with meta-analysis. Current medical research and opinion, 2013, Volume: 29, Issue:11 Topics: Conjunctivitis, Allergic; Cyproheptadine; Histamine Antagonists; Humans; Platelet Activating Factor; Rhinitis, Allergic, Perennial; Rhinitis, Allergic, Seasonal; Treatment Outcome; Urticaria	2013
Platelet activating factor in allergies. International journal of immunopathology and pharmacology, 2015, Volume: 28, Issue:4 Topics: Anaphylaxis; Asthma; Eosinophils; Humans; Mast Cells; Platelet Activating Factor; Urticaria	2015
Rupatadine: global safety evaluation in allergic rhinitis and urticaria. Expert opinion on drug safety, 2016, Volume: 15, Issue:10 Topics: Animals; Anti-Allergic Agents; Blood-Brain Barrier; Cyproheptadine; Histamine H1 Antagonists; Humans; Platelet Activating Factor; Rhinitis, Allergic; Urticaria	2016
Rupatadine for the treatment of allergic rhinitis and urticaria. Expert review of clinical immunology, 2011, Volume: 7, Issue:1 Topics: Anti-Allergic Agents; Chronic Disease; Cyproheptadine; Histamine H1 Antagonists; Humans; Platelet Activating Factor; Rhinitis, Allergic, Perennial; Rhinitis, Allergic, Seasonal; Treatment Outcome; Urticaria	2011
Rupatadine: a review of its use in the management of allergic disorders. Drugs, 2007, Volume: 67, Issue:3 Topics: Adolescent; Adult; Aged; Animals; Anti-Allergic Agents; Cyproheptadine; Drug Interactions; Humans; Hypersensitivity; Platelet Activating Factor; Rhinitis, Allergic, Perennial; Rhinitis, Allergic, Seasonal; Urticaria	2007
Rupatadine in allergic rhinitis and chronic urticaria. Allergy, 2008, Volume: 63 Suppl 87 Topics: Adolescent; Animals; Anti-Allergic Agents; Child; Chronic Disease; Clinical Trials as Topic; Cyproheptadine; Dogs; Humans; Platelet Activating Factor; Rhinitis, Allergic, Perennial; Rhinitis, Allergic, Seasonal; Treatment Outcome; Urticaria	2008
The pathophysiology of chronic urticaria. Clinical reviews in allergy, 1992,Winter, Volume: 10, Issue:4 Topics: Chronic Disease; Histamine; Humans; Immunoglobulin E; Kinins; Leukotrienes; Mast Cells; Platelet Activating Factor; Prostaglandins; Urticaria	1992
Mast cell mediators in the blood of patients with asthma. Chest, 1985, Volume: 87, Issue:1 Suppl Topics: Adenosine; Antigens; Asthma; Bronchial Spasm; Chemotactic Factors; Histamine; Humans; Mast Cells; Platelet Activating Factor; Urticaria	1985

Trials

3 trial(s) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Urticaria

Article	Year
Levocetirizine and rupatadine in chronic idiopathic urticaria. International journal of dermatology, 2015, Volume: 54, Issue:10 Topics: Adolescent; Adult; Aged; Cetirizine; Child; Chronic Disease; Cyproheptadine; Female; Histamine H1 Antagonists; Histamine H1 Antagonists, Non-Sedating; Humans; Male; Middle Aged; Platelet Activating Factor; Quality of Life; Severity of Illness Index; Tumor Necrosis Factor-alpha; Urticaria; Young Adult	2015
Rupatadine and its effects on symptom control, stimulation time, and temperature thresholds in patients with acquired cold urticaria. Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 2010, Volume: 104, Issue:1 Topics: Adult; Cold Temperature; Cyproheptadine; Double-Blind Method; Environmental Exposure; Female; Histamine Antagonists; Humans; Male; Middle Aged; Platelet Activating Factor; Pruritus; Treatment Outcome; Urticaria	2010
Effects of H1- and H2-antihistamines on platelet-activating factor and bradykinin-induced inflammatory responses in human skin. Clinical and experimental dermatology, 1996, Volume: 21, Issue:1 Topics: Administration, Oral; Bradykinin; Cimetidine; Codeine; Double-Blind Method; Doxepin; Histamine; Histamine H1 Antagonists; Histamine H2 Antagonists; Humans; Platelet Activating Factor; Skin; Terfenadine; Urticaria	1996

Other Studies

15 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Urticaria

Article	Year
Serum Levels of Vascular Endothelial Growth Factor, Platelet Activating Factor and Eosinophil-Derived Neurotoxin in Chronic Spontaneous Urticaria-A Pilot Study in Adult Patients. International journal of molecular sciences, 2022, Aug-25, Volume: 23, Issue:17 Topics: Adult; Chronic Disease; Chronic Urticaria; Cytokines; Eosinophil-Derived Neurotoxin; Humans; Pilot Projects; Platelet Activating Factor; Pruritus; Urticaria; Vascular Endothelial Growth Factor A	2022
Anti-heat shock protein 10 IgG in chronic spontaneous urticaria: Relation with miRNA-101-5p and platelet-activating factor. Allergy, 2023, Volume: 78, Issue:12 Topics: Autoantibodies; Chronic Disease; Chronic Urticaria; Humans; Immunoglobulin G; Interleukin-4; MicroRNAs; Platelet Activating Factor; Urticaria	2023
Treatment of acquired cold urticaria with rupatadine. Allergy, 2009, Volume: 64, Issue:9 Topics: Adult; Chronic Disease; Cold Temperature; Cyproheptadine; Female; Humans; Middle Aged; Platelet Activating Factor; Treatment Outcome; Urticaria	2009
Platelet-activating factor (PAF) induces wheal and flare skin reactions independent of mast cell degranulation. Allergy, 2013, Volume: 68, Issue:2 Topics: Adult; Cell Degranulation; Codeine; Female; Germany; Histamine; Histamine Release; Humans; Injections, Intradermal; Male; Mast Cells; Microdialysis; Platelet Activating Factor; Reference Values; Sampling Studies; Skin; Skin Tests; Urticaria; Young Adult	2013
Inflammatory mediators and mechanisms of release from purified human basophils and mast cells. The Journal of allergy and clinical immunology, 1984, Volume: 74, Issue:4 Pt 1 Topics: Basophils; Cell Separation; Cold Temperature; Histamine Release; Humans; Mast Cells; Models, Biological; Physical Exertion; Platelet Activating Factor; Prostaglandin D2; Prostaglandins D; Urticaria	1984
Increased monocyte chemotaxis towards leukotriene B4 and platelet activating factor in patients with inflammatory dermatoses. Clinical and experimental immunology, 1983, Volume: 54, Issue:2 Topics: Adolescent; Adult; Cells, Cultured; Chemotaxis, Leukocyte; Child; Dermatitis; Dermatitis, Atopic; Dose-Response Relationship, Immunologic; Female; Humans; Leukotriene B4; Male; Monocytes; Platelet Activating Factor; Psoriasis; Urticaria	1983
Histamine releasability of basophils and skin mast cells in chronic urticaria. Allergy, 1996, Volume: 51, Issue:1 Topics: Adult; Antibodies, Anti-Idiotypic; Basophils; Calcimycin; Cimetidine; Female; Histamine Release; Humans; Immunoglobulin E; Interleukin-3; Leukotriene C4; Male; Mast Cells; Middle Aged; N-Formylmethionine Leucyl-Phenylalanine; Platelet Activating Factor; Skin; Urticaria	1996
Effects of antihistamines on cutaneous reactions and influx of eosinophils after local injection of PAF, kallikrein, compound 48/80 and histamine in patients with chronic urticaria and healthy subjects. Acta dermato-venereologica, 1992, Volume: 72, Issue:3 Topics: Adult; Aged; Chlorpheniramine; Chronic Disease; Eosinophils; Female; Histamine; Histamine H1 Antagonists; Humans; Kallikreins; Loratadine; Male; Middle Aged; p-Methoxy-N-methylphenethylamine; Platelet Activating Factor; Skin; Urticaria	1992
Release of mediators from human gastric mucosa and blood in adverse reactions to benzoate. International archives of allergy and applied immunology, 1991, Volume: 96, Issue:2 Topics: 6-Ketoprostaglandin F1 alpha; Adolescent; Adult; Aged; Asthma; Benzoates; Benzoic Acid; Dermatitis, Atopic; Endoscopy, Gastrointestinal; Female; Food Additives; Gastric Mucosa; Histamine; Histamine Release; Humans; Male; Middle Aged; Monocytes; Platelet Activating Factor; Urticaria	1991
Effect of cetirizine on cutaneous reactions to PAF, kallikrein and serum in patients with chronic urticaria. Acta dermato-venereologica, 1990, Volume: 70, Issue:2 Topics: Adult; Blood Transfusion, Autologous; Cetirizine; Chronic Disease; Female; Histamine; Histamine H1 Antagonists; Humans; Hydroxyzine; Hypersensitivity, Delayed; Injections, Intradermal; Kallikreins; Male; Middle Aged; Platelet Activating Factor; Urticaria	1990
Late-phase cutaneous reactions to platelet activating factor and kallikrein in urticaria. Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology, 1990, Volume: 20 Suppl 4 Topics: Adult; Cetirizine; Chronic Disease; Female; Histamine H1 Antagonists; Humans; Hydroxyzine; Hypersensitivity, Delayed; Injections, Intradermal; Kallikreins; Male; Middle Aged; Platelet Activating Factor; Skin; Urticaria	1990
[Allergy and PAF]. Tanpakushitsu kakusan koso. Protein, nucleic acid, enzyme, 1991, Volume: 36, Issue:3 Topics: Anaphylaxis; Animals; Asthma; Humans; Leukocytes; Macrophages; Mast Cells; Platelet Activating Factor; Rhinitis, Allergic, Perennial; Urticaria	1991
Association of platelet-activating factor with primary acquired cold urticaria. The New England journal of medicine, 1985, Aug-15, Volume: 313, Issue:7 Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Adult; Angioedema; Biological Assay; Chemotaxis, Leukocyte; Chromatography, Thin Layer; Cold Temperature; Female; Histamine Release; Humans; Male; Phospholipases A; Platelet Activating Factor; Serotonin; Tritium; Urticaria	1985
Mediators of heat urticaria. Clinical and experimental dermatology, 1988, Volume: 13, Issue:6 Topics: Hot Temperature; Humans; Platelet Activating Factor; Urticaria	1988
Effects of BN 52063 on PAF-acether induced weal and flare in man. Agents and actions. Supplements, 1987, Volume: 21 Topics: Adult; Dose-Response Relationship, Drug; Humans; Lactones; Male; Plant Extracts; Platelet Activating Factor; Skin; Urticaria	1987